Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Archi Indonesia Tbk (ARCI) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Archi Indonesia TbkTrade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Archi Indonesia Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Archi Indonesia Tbk trades at Rp1,215 (market cap 30.28T, 10.93M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp230 (market cap 319B, 44.8K 24h volume). The key difference: Archi Indonesia Tbk is far larger — about 94.9× Diagnos Laboratorium Utama Tbk.'s market cap, and Archi Indonesia Tbk is more actively traded (10.93M versus 44.8K). Which is the better fit depends on your goals.

ARCIDGNS
Market Cap
30.28T319B
Volume
10.93M44.8K
Lot
109.34K448
Turnover
13.11B10.23M
Average Price
1,198.67228.26
Value
13.11B10.23M
Indicative Equilibrium Price
1,180232
Indicative Equilibrium Volume
3.67K200

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ARCI
View details
DGNS
View details

About Archi Indonesia Tbk

PT Archi Indonesia Tbk. (the Company) was established based on Notarial Deed No. 1 of Fatma Agung Budiwijaya, S.H., dated September 14, 2010. The Company commenced its commercial operations in 2010 and is primarily involved in investment holding. PT Rajawali Corpora is the Companys parent and ultimate parent entity.

Read more on ARCI

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS